Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.65 USD 2.07% Market Closed
Market Cap: 145.4B USD
Have any thoughts about
Pfizer Inc?
Write Note

Relative Value

The Relative Value of one PFE stock under the Base Case scenario is 33.17 USD. Compared to the current market price of 25.65 USD, Pfizer Inc is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PFE Relative Value
Base Case
33.17 USD
Undervaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
37
Median 3Y
2.6
Median 5Y
3
Industry
2.5
Forward
2.3
vs History
7
vs Industry
5
Median 3Y
8.9
Median 5Y
10.5
Industry
21.9
Forward
8.7
vs History
12
vs Industry
22
Median 3Y
9
Median 5Y
11.5
Industry
16.5
vs History
6
vs Industry
34
Median 3Y
9.6
Median 5Y
8.6
Industry
23.6
vs History
95
vs Industry
42
Median 3Y
2
Median 5Y
2.5
Industry
2.1
vs History
61
vs Industry
29
Median 3Y
3
Median 5Y
3.7
Industry
2.6
Forward
3.2
vs History
63
vs Industry
37
Median 3Y
4.7
Median 5Y
5.2
Industry
5.2
vs History
57
vs Industry
28
Median 3Y
7.3
Median 5Y
10.9
Industry
13.3
Forward
8.4
vs History
52
vs Industry
20
Median 3Y
8.9
Median 5Y
15.8
Industry
16.6
Forward
10.7
vs History
9
vs Industry
17
Median 3Y
9.4
Median 5Y
13.9
Industry
15.6
vs History
14
vs Industry
10
Median 3Y
10.7
Median 5Y
17
Industry
19.1
vs History
96
vs Industry
54
Median 3Y
1.3
Median 5Y
1.3
Industry
1.9

Multiples Across Competitors

PFE Competitors Multiples
Pfizer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Pfizer Inc
NYSE:PFE
145.4B USD 2.4 34.2 10.3 15.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
US
Pfizer Inc
NYSE:PFE
Average P/E: 32.6
34.2
733%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top